AKT1 and breast carcinoma: Mutations of mTOR and Akt are much less frequent, although, they were demonstrated in melanoma, renal carcinoma, bladder tumor, lung cancer, breast cancers, head and neck squamous cell carcinomas, and endometrial cancer [124].